NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
In the last 90 days, NeuroPace Inc insiders filed 3 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q3 2026, worth $369.0M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $283.2M
- Insider buysLast 90 days, $302.1K in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, −6 vs. previous quarter
- 104
- 13F valueReported value at the end of Q3 2026
- $369.0M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $100.0M
- +25.1% year over year
- Net income, FY2025
- -$21.5M
- No comparable prior period
- Free cash flow, FY2025
- -$11.3M
- No comparable prior period
- Revenue, Q3 FY2026
- $23.1M
- −15.5% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $21.5M (21.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 858.3K
- Shares sold short
- Change
- −27.9K
- −3.2% vs. previous
- Days to cover
- 8.48
- At average daily volume
Superinvestors holding NPCE, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding NPCE at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by NeuroPace Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)5:09 PM ET | Nov 18 | Same day | Huennekens R ScottDirector | PPurchase | +12.5K | $8.29 | +$103.7K | New position12.5K after | |
| Nov 17, 2026 (view filing)5:10 PM ET | Nov 17 | Same day | Williams Patrick F.Chief Financial Officer | PPurchase | +11.9K | $8.34 | +$99.1K | +17.6%79.4K after | |
| Nov 17, 2026 (view filing)5:08 PM ET | Nov 17 | Same day | Becker JoelCHIEF EXECUTIVE OFFICER | PPurchase | +11.9K | $8.35 | +$99.3K | +8.6%149.9K after | |
| Mar 4, 2026 (view filing) | Dec 15, 2025 | 79 daysLate | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −25.0K | $15.97 | −$399.3K | −33.3%50.0K after | |
| May 16, 2025 (view filing)5:26 PM ET | May 14 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −168.1K | $15.85 | −$2.67M | −4.9%3.24M after | 2 lots |
| Feb 25, 2025 (view filing) | Feb 21 | 4 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −78.3K | $13.72 | −$1.07M | −48.9%82.0K after | |
| Feb 20, 2025 (view filing) | Feb 20 | Same day | KCK Ltd.10% Owner | SSale | −5.27M | $9.40 | −$49.5M | −100.0%0 after | |
| Jan 31, 2025 (view filing) | Jan 29-30 | 2 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −300 | $15.00 | −$4.50K | −0.3%86.8K after | 2 lots10b5-1 |
| Jan 28, 2025 (view filing) | Jan 24 | 4 days | Morrell MarthaCHIEF MEDICAL OFFICER | SSale | −3.20K | $15.01 | −$48.0K | −3.5%87.1K after | 10b5-1 |
| Oct 28, 2024 (view filing) | Oct 23-25 | 5 daysLate | KCK Ltd.10% Owner | SSale | −224.1K | $5.45 | −$1.22M | −4.1%5.27M after | 2 lots |
Top 10 13F holders, Q3 2026
See all 104 holdersThe largest institutional positions in NeuroPace Inc at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 3,983,577 | $54.8M | 3.25% | +1,122,410+39.2% | Added |
| Polar Capital Holdings Plc | 3,298,104 | $45.4M | 0.13% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 3,218,000 | $44.3M | 1.57% | +306,878+10.5% | Added |
| Morgan Stanley | 2,568,872 | $35.3M | 0.00% | −85,519−3.2% | Reduced |
| BlackRock, Inc. | 2,467,499 | $34.0M | 0.00% | −10,104−0.4% | Reduced |
| Driehaus Capital Management LLC | 1,429,439 | $19.7M | 0.14% | −17,952−1.2% | Reduced |
| Vanguard Capital Management LLC | 1,234,175 | $17.0M | 0.00% | +7,103+0.6% | Added |
| OrbiMed Advisors LLC | 1,055,125 | $14.5M | 0.27% | −450,000−29.9% | Reduced |
| Deutsche Bank AG | 935,652 | $12.9M | 0.00% | −3,267−0.3% | Reduced |
| Armistice Capital, LLC | 800,000 | $11.0M | 0.37% | +108,000+15.6% | Added |
Holders of 5% or more of NPCE
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of NeuroPace Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Light Asset Management, LLC | 13G/A | 12.25%4.20M shares | +3.58 ppfrom 8.67% | May 15, 20262 filings | Sep 4, 2026 | SEC |
| Polar Capital Holdings Plc | 13G | 9.13%2.97M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Soleus Private Equity Fund I, L.P. | 13G/A | 8.90%2.96M shares | – | Nov 1, 20216 filings | Nov 7, 2025 | SEC |
| Morgan Stanley | 13G/A | 8.30%2.49M shares | – | Feb 10, 20233 filings | Feb 4, 2025 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 7.00%2.30M shares | – | Aug 5, 20251 filing | Aug 5, 2025 | SEC |